A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Amazon One Medical Launches Visits for Perimenopause and Menopause CareHealthradar26. September 2025 What You Should Know: – Today, One Medical, Amazon’s national in-person and virtual primary care practice, announced the launch of…
